Review
Resistance to aspirin: Prevalence, mechanisms of action and association with thromboembolic events. A narrative review
Resistencia a la aspirina: prevalencia, mecanismos de acción y asociación con eventos tromboembólicos. Revisión narrativa
Leído
3194
Vecesse ha leído el artículo
1333
Total PDF
1861
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 6 | 52 | 8 | 60 |
| 2025 5 | 100 | 48 | 148 |
| 2025 4 | 70 | 32 | 102 |
| 2025 3 | 88 | 25 | 113 |
| 2025 2 | 57 | 21 | 78 |
| 2025 1 | 56 | 34 | 90 |
| 2024 12 | 55 | 20 | 75 |
| 2024 11 | 49 | 21 | 70 |
| 2024 10 | 48 | 24 | 72 |
| 2024 9 | 54 | 18 | 72 |
| 2024 8 | 42 | 23 | 65 |
| 2024 7 | 34 | 23 | 57 |
| 2024 6 | 37 | 32 | 69 |
| 2024 5 | 34 | 15 | 49 |
| 2024 4 | 51 | 13 | 64 |
| 2024 3 | 45 | 17 | 62 |
| 2024 2 | 48 | 17 | 65 |
| 2024 1 | 33 | 26 | 59 |
| 2023 12 | 35 | 20 | 55 |
| 2023 11 | 30 | 36 | 66 |
| 2023 10 | 39 | 24 | 63 |
| 2023 9 | 29 | 20 | 49 |
| 2023 8 | 22 | 6 | 28 |
| 2023 7 | 27 | 8 | 35 |
| 2023 6 | 29 | 26 | 55 |
| 2023 5 | 27 | 34 | 61 |
| 2023 4 | 22 | 9 | 31 |
| 2023 3 | 17 | 19 | 36 |
| 2023 2 | 22 | 61 | 83 |
| 2022 1 | 19 | 9 | 28 |
| 2022 12 | 12 | 8 | 20 |
| 2022 11 | 15 | 9 | 24 |
| 2022 10 | 15 | 13 | 28 |
| 2022 9 | 7 | 23 | 30 |
| 2022 8 | 19 | 15 | 34 |
| 2022 7 | 18 | 12 | 30 |
| 2022 6 | 16 | 11 | 27 |
| 2022 5 | 10 | 5 | 15 |
| 2022 4 | 8 | 16 | 24 |
| 2022 3 | 9 | 15 | 24 |
| 2022 2 | 10 | 3 | 13 |
| 2021 1 | 14 | 10 | 24 |
| 2021 12 | 5 | 7 | 12 |
| 2021 11 | 15 | 8 | 23 |
| 2021 10 | 4 | 5 | 9 |
| 2021 9 | 8 | 8 | 16 |
| 2021 8 | 6 | 9 | 15 |
| 2021 7 | 9 | 7 | 16 |
| 2021 6 | 6 | 6 | 12 |
| 2021 5 | 3 | 9 | 12 |
| 2021 4 | 18 | 15 | 33 |
| 2021 3 | 5 | 5 | 10 |
| 2021 2 | 5 | 10 | 15 |
| 2020 1 | 13 | 7 | 20 |
| 2020 12 | 4 | 10 | 14 |
| 2020 11 | 5 | 10 | 15 |
| 2020 10 | 5 | 11 | 16 |
| 2020 9 | 7 | 9 | 16 |
| 2020 8 | 9 | 10 | 19 |
| 2020 7 | 8 | 10 | 18 |
| 2020 6 | 3 | 8 | 11 |
| 2020 5 | 5 | 10 | 15 |
| 2020 4 | 11 | 7 | 18 |
| 2020 3 | 8 | 11 | 19 |
| 2020 2 | 2 | 8 | 10 |
| 2020 1 | 2 | 6 | 8 |
| 2019 12 | 6 | 10 | 16 |
| 2019 11 | 1 | 8 | 9 |
| 2019 10 | 5 | 18 | 23 |
| 2019 9 | 4 | 7 | 11 |
| 2019 8 | 1 | 9 | 10 |
| 2019 7 | 3 | 17 | 20 |
| 2019 6 | 19 | 18 | 37 |
| 2019 5 | 54 | 14 | 68 |
| 2019 4 | 24 | 12 | 36 |
| 2019 3 | 4 | 1 | 5 |
| 2019 2 | 3 | 3 | 6 |
| 2019 1 | 1 | 5 | 6 |
| 2018 12 | 1 | 12 | 13 |
| 2018 11 | 3 | 5 | 8 |
| 2018 10 | 4 | 14 | 18 |
| 2018 9 | 1 | 0 | 1 |
| 2018 8 | 16 | 4 | 20 |
| 2018 7 | 0 | 6 | 6 |
| 2018 6 | 2 | 3 | 5 |
| 2018 5 | 4 | 8 | 12 |
| 2018 4 | 2 | 23 | 25 |
| 2018 3 | 0 | 5 | 5 |
| 2018 2 | 0 | 4 | 4 |
| 2018 1 | 2 | 0 | 2 |
| 2017 12 | 3 | 4 | 7 |
| 2017 11 | 5 | 0 | 5 |
| 2017 10 | 6 | 5 | 11 |
| 2017 9 | 5 | 4 | 9 |
| 2017 8 | 3 | 8 | 11 |
| 2017 7 | 6 | 1 | 7 |
| 2017 6 | 8 | 7 | 15 |
| 2017 5 | 7 | 18 | 25 |
| 2017 4 | 7 | 9 | 16 |
| 2017 3 | 9 | 11 | 20 |
| 2017 2 | 7 | 4 | 11 |
| 2016 1 | 5 | 7 | 12 |
| 2016 12 | 10 | 5 | 15 |
| 2016 11 | 6 | 6 | 12 |
| 2016 10 | 9 | 1 | 10 |
| 2016 9 | 5 | 0 | 5 |
| 2016 8 | 8 | 1 | 9 |
| 2016 7 | 2 | 1 | 3 |
Mostrar todo
